Medicine top-ups to be allowed

November 5, 2008
Sales and Marketing NICE, par

The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …

Bayer’s ‘revolutionary’ anticoagulant Xarelto launched

November 4, 2008
Sales and Marketing Xarelto

Xarelto, the new anticoagulant treatment from Bayer has been launched in the UK, and is set to be among a …

The rise and rise of the interim manager

November 3, 2008
Business Services interim management, recruitment

Interim management is now a popular choice in pharma marketing, both for companies looking to recruit for short spells, and …

Latest news from Datamonitor

November 3, 2008
Sales and Marketing Acomplia, Sanofi

Acomplia's EU suspension dispels illusion of blockbuster futureThe EMEA has suspended Acomplia due to the risk of serious psychiatric disorders. …

Call for more not-for-profit healthcare providers

October 30, 2008
Sales and Marketing NHS, hc

Healthcare provision should increasingly be modelled along social enterprise lines, according to the NHS Alliance. Not-for-profit groups of out-of-hours providers …

Contraceptive and Betaferon sales bolster Bayer

October 30, 2008
Sales and Marketing Bayer

Strong sales of Bayer's Yaz contraceptives and multiple sclerosis treatment Betaferon have helped third quarter pharma sales that could only …

Study boost for Roche’s Actemra

October 30, 2008
Research and Development, Sales and Marketing RA, Roche

New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …

Alzheimer’s companies hope renewed by House of Lords

October 30, 2008
Sales and Marketing Alzheimer's, NICE

The companies behind Alzheimer's drug Aricept have won the right to see the economic model NICE used to assess the …

Strong results for Novartis drug in rare autoimmune disease

October 30, 2008
Research and Development, Sales and Marketing Novartis

Novartis' development drug ACZ885 (canakinumab) has turned in impressive results in trials for rare medical conditions. It showed sustained remission …

GSK to acquire Hepatitis C specialists Genelabs

October 30, 2008
Sales and Marketing GSK, Genelabs, MA

GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …

Specialising for success

October 29, 2008
Research and Development, Sales and Marketing marketing, product portfolio

From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …

Latest news from Datamonitor

October 28, 2008
Sales and Marketing

Targeted therapy cancer brands to achieve sales of over $42 billion by 2017Targeted therapies have improved treatment outcomes in cancer …

Novartis appoints Reinhardt as chief operating officer

October 24, 2008
Sales and Marketing Novartis

Novartis has shaken up its senior management structure with the creation of a new post – chief operating officer. From …

Merck to streamline management structure

October 24, 2008
Sales and Marketing Merck

Merck has announced a new round of job cuts and restructuring in a bid to update its business model and …

Roche dips on Tamiflu decline

October 24, 2008
Sales and Marketing Roche

Roche's sales dropped 2% to 33.3 billion Swiss francs in the first nine months of 2008, due to a sharp …

Leaders use war gaming to strengthen UK biotech

October 22, 2008
Research and Development, Sales and Marketing biotech

Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …

PPRS talks stall

October 22, 2008
Sales and Marketing par

Talks on the future of pharmaceutical pricing scheme the PPRS have stumbled into trouble, after it emerged a major part …

The Gateway to Local Adoption Series

Latest content